miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing

被引：66

作者：

Guerau-de-Arellano, Mireia ^{[1
,2
]}

Alder, Hansjuerg ^{[3
]}

Ozer, Hatice Gulcin ^{[4
]}

Lovett-Racke, Amy ^{[3
]}

Racke, Michael K. ^{[1
]}

机构：

[1] Ohio State Univ, Med Ctr, Dept Neurol, Columbus, OH 43210 USA

[2] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA

[3] Ohio State Univ, Med Ctr, Mol Virol Immunol & Med Genet Dept, Columbus, OH 43210 USA

[4] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 248卷 / 1-2期

关键词：

miRNA; Profiling; Biomarker; Multiple sclerosis; Neuroimmunology; Autoimmunity; MYELIN BASIC-PROTEIN; MICRORNA GENES; C-ELEGANS; RNA-INTERFERENCE; T-CELLS; EXPRESSION; DIFFERENTIATION; AUTOIMMUNITY; BIOGENESIS; TARGETS;

D O I：

10.1016/j.jneuroim.2011.10.006

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. miRNAs are highly expressed in cells of the immune and nervous system, attesting to their importance in Neuroimmunology. Besides their involvement in modulation of physiological and pathological processes, miRNAs hold high promise as disease biomarkers, therapeutic agents and/or drug targets. Several studies have recently explored the involvement of miRNAs in Multiple Sclerosis (MS) using a variety of miRNA profiling techniques. In this review, we discuss basic miRNA biology and nomenclature, the techniques available for miRNA profiling research and recent miRNA profiling studies in Multiple Sclerosis. (C) 2011 Elsevier B.V. All rights reserved.

引用

页码：32 / 39

页数：8

共 50 条

[1] MI-RNA PROFILING FOR BIOMARKER DISCOVERY IN MULTIPLE SCLEROSIS
Racke, Michael
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 876 - 876
[2] Applying targeted Next-Gen Sequencing and miRNA expression profiling for cancer biomarker discovery
Leonard, Jack T.
CANCER RESEARCH, 2010, 70
[3] Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus
Geeta Rai
Richa Rai
Amir Hossein Saeidian
Madhukar Rai
Immunologic Research, 2016, 64 : 14 - 24
[4] Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus
Rai, Geeta
Rai, Richa
Saeidian, Amir Hossein
Rai, Madhukar
IMMUNOLOGIC RESEARCH, 2016, 64 (01) : 14 - 24
[5] Global miRNA profiling for biomarker discovery - What is normal?
Tonge, Daniel
Gant, Timothy
TOXICOLOGY LETTERS, 2014, 229 : S22 - S22
[6] Proteomics technologies for biomarker discovery in multiple sclerosis
Singh, Vaibhav
Hintzen, Rogier Q.
Luider, Theo M.
Stoop, Marcel P.
JOURNAL OF NEUROIMMUNOLOGY, 2012, 248 (1-2) : 40 - 47
[7] New technologies for biomarker discovery in multiple sclerosis
Comabella, Manuel
Racke, Michael K.
JOURNAL OF NEUROIMMUNOLOGY, 2012, 248 (1-2) : 1 - 1
[8] scRNA-Sequencing and 21-Color Flow Cytometry For Biomarker Discovery in Multiple Sclerosis
Thai, K.
Tastet, O.
Rebillard, R.
Hoornaert, C.
Grasmuck, C.
Selmi, O.
Carrier, F.
Bourbonniere, L.
Gowing, E.
Girard, M.
Duquette, P.
Lahav, B.
Roger, E.
Arbour, N.
Larochelle, C.
Zandee, S.
Prat, A.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 44 - 45
[9] Integrated Genomic, MicroRNA (miRNA) and Proteomic Profiling of Ovarian Carcinoma for Biomarker Discovery
Bayani, Jane
Kuzmanov, Uros
Batruch, Ihor
Cho, Chan-Kyung
Smith, Chris
Marrano, Paula
Graham, Cassandra
Butzow, Ralf
Katsaros, Dionyssios
Lin, Li
Zheng, Yingye
Squire, Jeremy A.
Diamandis, Eleftherios P.
CANCER RESEARCH, 2010, 70
[10] miRNA profiling in Teriflunomide treated multiple sclerosis (MS) patients
Paul, A.
Rosso, M.
Healy, B.
Gandhi, R.
Kivisakk, P.
Glanz, B.
Chitnis, T.
Weiner, H.
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 343 - 344

← 1 2 3 4 5 →